 |
| Serum Chief Adar Poonawalla . |
Serum Institute of India announced that it can manufacture 9 to 10 crore doses of Covishield in June
In a recent letter to Amit Shah, Serum Institute said its staff has been working round the clock to meet the rising demand for the Covid vaccines in the country.
"We are pleased to inform that in the month of June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to the country as compared to our production capacity of 6.5 crore doses in May," Prakash Kumar Singh, the Director of Government and Regulatory Affairs at SII, said in the letter.
Mr. Singh also thanked Shah for his "valuable guidance and continuous support" at various stages of their endeavour to make India 'aatmanirbhar' (self-sufficient) in COVID-19 vaccines and making it available for the people of the country.
India is currently using made-in-India vaccines -- Covishield manufactured by Serum Institute of India and Covaxin of Bharat Biotech -- in its COVID-19 immunisation programme.
The Russian Sputnik V is the third vaccine to get approval from the Drug Controller General of India (DCGI) for emergency use and is being used in a few private hospitals. — PTI
No comments:
Post a Comment